🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

A Cross-Sectional Observational Study on Retained Drug Needle Fragments in People Who Use Intravenous Drugs

Recruitingn/aAges 18 Years - anyAllTampere University Hospital
NCT05679284 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

In addition to the well-known toxicological harms of intravenous drug (IVD) use, there can also be local tissue complications, including infections, venous sclerosis, tissue necrosis, and drug needle fragment retentions. Drug needle fragments in subcutaneous tissue may cause local symptoms (usually pain and infections), but they have also been identified as causing emboli to organs. The literature has described numerous case reports of people who inject drugs (PWIDs) and have retained needle fragments. The prevalence of the condition is not known, and the researchers therefore aim to perform the first cross-sectional study of PWIDs to estimate how common needle fragment retentions are and what their risk factors are in this population.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * History of intravenous drug use * Current treatment of the drug abuse problem at a local low-threshold drug abuse service unit or primary health care centre. * Adherence to fill in the questionnaire * Participation to X-ray imaging of injection sites Exclusion Criteria: * No history of intravenous drug use * Does not adhere to fill in the questionnaire or refuses X-ray imaging * Pregnancy * Underage (18 years old)
💊

What it tests

  • Low-dose X-ray of subcutaneous tissues
📍

Where

1 site
Hatanpää Health Center
Tampere, Finland
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy